PATIENT SAFETY
Getting a new product adopted into the NHS can feel like an unsurmountable challenge, given the often complicated and fragmented procurement processes.
and now there are programs available for all stages of development, however big or small. Nowadays many government-funded research bodies, such as the Medical Research Council (MRC), are increasingly placing emphasis on translational research, including funding streams which fund drug discovery clinical trials. Similarly, there are various government- funded initiatives which were set up to accelerate innovation and healthcare improvements by funding and facilitating cross-disciplinary development. The AHSNs are part of that initiative, as well as the National Institute for Health Research (NIHR), which has substantial funding from the government’s Department of Health and Social Care. Both the NIHR and the AHSNs are focused on connecting the various stakeholders within the healthcare innovation pathway and have access to funds to help innovators develop their technologies. For example, the SBRI healthcare development contract is funded by NHS England and will fund up to £1 million of non-dilutive funding for the development of innovations within
healthcare to meet unmet needs within the NHS. Similarly, the NIHR funds various programmes for all stages of the development pathway.
The pathway to innovation
Evidently, there are the means to develop innovative products from academia into the hands of patients but knowing how and when to access these tools can be a real challenge. It is no secret that innovation is difficult, let alone when trying to crack the beast that is the NHS, which is why engaging with experts and industry is key to the success of innovation.
The best success stories come from teams of people who have worked collaboratively together, drawing on various experiences and specific knowledge over time to deliver a new solution to an unmet clinical need. These successes do not happen overnight, and they do not happen in isolation. By collaborating and sharing ideas with the right people, it is never too early for researchers to begin navigating the pathway to innovation.
About the author
Chloe Moss is an analyst at Health Enterprise East, a not-for profit consultancy, placed at the interface between the NHS and industry, offering services such as commercial strategy development, procurement advice, health economics, IP development and more. HEE works with clinicians, academics and small to medium sized enterprises (SMEs) to help develop their innovations into viable commercial realities. Chloe brings to HEE her knowledge and expertise from her extensive experience in biomedical research. Chloe has a Bsc in Chemistry and a PhD in molecular biology from UCL. She has worked as an academic researcher at Yale University, the Francis Crick Institute and Cambridge University before joining HEE’s MedTech Consulting team in October 2018.
CSJ
A one-day conference for teams involved in Endoscope decontamination - from front line decontamination technicians up to senior management supporting Trusts, to guarantee a team approach to patient safety.
Compliance
ENDOSCOPE DECONTAMINATION CONFERENCE
Thursday 7th November 2019 Macdonald Hotel, Manchester
Med
T. 01223 440 475 E.
enquiries@iM-Med.com W.
iM-Med.com iM Med Ltd, 1b Pembroke Ave, Waterbeach, Cambridge CB25 9QP
Official Distributor for Expert speakers include:
Mr Floyd Woodraw: renowned speaker on leadership and performance
Dr Helen Griffiths:
Decontamination Advisor, British Society of Gastroenterology
Mr Wayne Spencer: Authorising Engineer Decontamination
ATTENDANCE IS FREE
To book your place, please email your:
- Full Name and Title - Hospital Trust and Dept - Telephone No. and Email
to:
education@iM-Med.com
AUGUST 2019
WWW.CLINICALSERVICESJOURNAL.COM I
69
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
